Human Investing’s Verastem VSTM Stock Holding History

Human Investing’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-125	Closed	-$3K	–	337
2020 Q2	$3K	Buy	+125	New	+$3.31K	﹤0.01%	276
2020 Q1	–	Sell	-250	Closed	-$4K	–	386
2019 Q4	$4K	Buy	+250	New	+$3.59K	﹤0.01%	326

Other funds holding VSTM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GCM

Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Human Investing's VSTM Position: Q3 2020 in Review

Human Investing sold out of Verastem (VSTM) in Q3 2020, closing a stake of 125 shares — an estimated $3K sold.

Human Investing first reported a position in VSTM in Q4 2019 and held it in 2 quarters. The position peaked at $4K in Q4 2019. 122 funds tracked by Wall St. Rank hold VSTM as of Q3 2020.

Human Investing reported no remaining Verastem position as of Q3 2020 after selling out during the quarter.
Human Investing sold 125 Verastem shares in Q3 2020, an estimated $3K.
Human Investing first reported a position in Verastem in Q4 2019 and held it in 2 quarters.
Human Investing's Verastem position peaked at $4K in Q4 2019.
122 funds tracked by Wall St. Rank held Verastem as of Q3 2020.

Based on Human Investing's 13F filing for Q3 2020, filed 27 Oct 2020.